Page last updated: 2024-08-23

sufentanil and Hepatitis

sufentanil has been researched along with Hepatitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chai, X; Guo, F; Han, H; Shu, S; Wang, S; Yang, X; Yin, Y; Zhou, L; Zhou, W	1

Other Studies

1 other study(ies) available for sufentanil and Hepatitis

Article	Year
Sufentanil Protects the Liver from Ischemia/Reperfusion-Induced Inflammation and Apoptosis by Inhibiting ATF4-Induced TP53BP2 Expression. Inflammation, 2021, Volume: 44, Issue:3 Topics: Activating Transcription Factor 4; Animals; Anti-Inflammatory Agents; Apoptosis; Cell Hypoxia; Cell Line; Disease Models, Animal; Gene Expression Regulation; Hepatitis; Hepatocytes; Inflammation Mediators; Liver; Male; Rats, Inbred BUF; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; Sufentanil	2021

Article

Year

Sufentanil Protects the Liver from Ischemia/Reperfusion-Induced Inflammation and Apoptosis by Inhibiting ATF4-Induced TP53BP2 Expression.

Inflammation, 2021, Volume: 44, Issue:3

Topics: Activating Transcription Factor 4; Animals; Anti-Inflammatory Agents; Apoptosis; Cell Hypoxia; Cell Line; Disease Models, Animal; Gene Expression Regulation; Hepatitis; Hepatocytes; Inflammation Mediators; Liver; Male; Rats, Inbred BUF; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; Sufentanil

2021